You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Coag-Lysis assay

Showing 1 - 25 of 2,083
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Determination of Fibrin Activity in Plasma on STA-R® Prototype

Completed
  • Blood Coagulation Disorders
  • +3 more
  • Routine hemostasis tests
  • +3 more
  • Clamart, France
    Hôpital d'Instruction des armées Percy - Laboratoire d'Hématolog
Aug 10, 2020

Patients Suffering From Acute Non-traumatic Subarachnoid

Recruiting
  • Subarachnoid Hemorrhage
    • Debrecen, Hajdú-Bihar, Hungary
      Dr. Szántó Dorottya
    Jun 27, 2022

    Prostasomes as Diagnostic Tool for Prostate Cancer Detection

    Suspended
    • Prostate Cancer
    • Genetic analysis for the detection of prostasomes
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Nov 28, 2022

    Diabetes Trial in Dundee, Glasgow, Kirkcaldy (Venepuncture, Fingerstick)

    Active, not recruiting
    • Diabetes
    • Venepuncture
    • Fingerstick
    • Dundee, United Kingdom
    • +3 more
    Sep 28, 2022

    Pancreatic Diseases Trial in Shanghai (Red cell lysis buffer (RCLB) application, Conventional processing)

    Not yet recruiting
    • Pancreatic Diseases
    • Red cell lysis buffer (RCLB) application
    • Conventional processing
    • Shanghai, Shanghai, China
      Changhai Hospital
    Jul 12, 2023

    Acute Deep Vein Thrombosis Trial in Kansas City (Thrombolysis in combination with endhole aspiration)

    Recruiting
    • Acute Deep Vein Thrombosis
    • Thrombolysis in combination with endhole aspiration
    • Kansas City, Kansas
      University of Kansas Medical Center
    Nov 1, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2022

    Atrial Fibrillation (COAG-AF) Pilot Study

    Recruiting
    • Atrial Fibrillation
      • New Orleans, Louisiana
        Tulane University Medical Center
      Nov 21, 2022

      Schizophrenia, Bipolar Disorder, Alzheimer Trial in Bron Cedex, Bron (blood sample taken)

      Recruiting
      • Schizophrenia
      • +3 more
      • blood sample taken
      • Bron Cedex, France
      • +1 more
      Oct 3, 2022

      Accuracy Evaluation of the IdentiClone Dx IGH Assay

      Not yet recruiting
      • B-Cell Lymphoproliferative Disorder
      • IdentiClone Dx IGH (IC IGH Dx) Assay
      • San Diego, California
      • +2 more
      Oct 30, 2023

      Pelvic Mass Trial in Houston (Hemipelvectomy, Tranexamic Acid)

      Recruiting
      • Pelvic Mass
      • Hemipelvectomy
      • Tranexamic Acid
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 14, 2022

      Thrombogenicity of Lipoprotein A: Laboratory Study Defining

      Not yet recruiting
      • Cardiovascular Disease and Lipid Disorders
      • Cardiac Disease
      • Non-interventional
      • Middlesbrough, Teesside, United Kingdom
        South Tees Hospitals NHS FT
      Apr 14, 2022

      Barrett Esophagus, Esophageal Cancer Trial in Baltimore (Educational materials on validated methylation assay)

      Active, not recruiting
      • Barrett Esophagus
      • Esophageal Cancer
      • Educational materials on validated methylation assay
      • Baltimore, Maryland
        Capsulomics, Inc.
      Apr 26, 2023

      Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

      Active, not recruiting
      • Aggressive B-Cell Non-Hodgkin Lymphoma
      • fractionated first dose rituximab
      • Geneva, Switzerland
        University Hospital Geneva
      Apr 21, 2023

      Renal Failure, Renal Insufficiency, Renal Disease Trial (H-Guard)

      Not yet recruiting
      • Renal Failure
      • +2 more
      • H-Guard
      • (no location specified)
      Oct 4, 2023

      Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)

      Recruiting
      • Acute Respiratory Failure
      • +2 more
      • Liverpool, New South Wales, Australia
        Intensive Care Unit, Liverpool Hospital, South Western Sydney Lo
      Sep 15, 2022

      Trial

      Completed
      Has Results
      • Healthy
      • Alinity s Anti-HCV II
      • Saint Paul, Minnesota
      • +3 more
      Sep 16, 2022

      Ovarian Cancer Trial in France (tests to determine HRD status)

      Not yet recruiting
      • Ovarian Cancer
      • tests to determine HRD status
      • Amiens, France
      • +3 more
      Nov 22, 2023

      Healthy Volunteers Trial (TBP-PI-HBr)

      Not yet recruiting
      • Healthy Volunteers
      • (no location specified)
      May 3, 2023

      Epithelial Ovarian Cancer Trial (ROMA score evaluation)

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • ROMA score evaluation
      • (no location specified)
      Aug 7, 2023

      Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

      Not yet recruiting
      • HIV Seropositivity
      • +2 more
      • HIV Ag +Ab Assay Kit (Sysmex)
      • (no location specified)
      Aug 1, 2023

      Cardiopulmonary Bypass Induced Red Blood Cell Lysis

      Recruiting
      • Cardiopulmonary Bypass
      • +2 more
      • Blood and urine collection
      • Baltimore, Maryland
        Center for Blood Oxygen Transport and Hemostasis
      Jun 29, 2022

      s Recurrence and Response Via a Tumor Informed Assessment

      Recruiting
      • Cancer
      • +4 more
      • Personalized Cancer Monitoring (PCM)
      • San Francisco, California
      • +1 more
      Dec 5, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Dec 5, 2022